Advertorial ITIND AND REZUM ARE AVAILABLE IN THAILAND

[ASEAN NOW Sales]

 

Urologists team led by Dr. Suntchai Wirotsaengthong in M Centre, BNH hospital, Bangkok, Thailand become the first team in Asia performing both Rezum and iTind – the latest minimally invasive procedures for Benign Prostatic Hyperplasia (BPH).

 

BPH is medical term of enlarged prostate. Normally, it happens with men in their 50s, when prostate, a walnut-shaped gland, starts to grow and presses on the urethra.

 

As the result, about half of men with BPH are suffering with bothersome symptoms like a weak urine flow, difficulty with starting urinate or emptying the bladder completely. It also gets men up at night and puts them in urgent situations almost the time. The sufferers may experience some embarrassing moments like urge to find the bathroom at restaurant, urge to find pit stops in long road trip, urge to make water when are having romantic time with their partners.

 

At certain level of severity, seeking medical attention is required. Oral medicine and transurethral resection of the prostate (TURP) are traditional methods. However, taking medicines in long-term and TURP cause unexpected side effects which erectile dysfunction and retrograde ejaculation are among them. That makes some men think twice before reaching out for a treatment.

Understanding the concerns of patients, Dr. Suntchai and his team have been striving to find new approaches to address patients symptoms without surgery.

 

Consequently, M Centre, BNH hospital, Bangkok, Thailand has been become a first Urological clinic where both iTind and Rezum – the latest minimally invasive procedures have been done.

 

iTind is the newest treatment for BPH. By using temporary nitinol device, it reshapes the prostatic urethra, gradually creating a wider opening through for urine to flow freely.

 

Rezum is using the natural energy stored in few drops of water to inject to the enlarged prostate tissue. The excessive tissues which are pressing on the urethra will be removed thanks to the heat from each 9-second-needle-treatment.

 

Both procedures can be done as outpatient treatments with light sedation and patients are able to go home in the same day. Most of them return to regular activities within a few days.

 

The efficacy of iTind and Rezum is demonstrated through significant symptomatic relief and durable improvement.

In detail, 3-year-study of iTind has shown that the symptoms score reduced 19% and the urinary flow rate improved 41%.

The corresponding numbers of Rezum are 48% and 44% reported by a 5-year-study.

 

More important, there is no adverse events related to sexual function caused by  these treatments were recorded.

All procedures are now U.S FDA approved in 2015 and 2020 respectively.

 

“We have to understand that there is no same treatment protocol for every cases. However, if you’re right candidate of either iTind or Rezum, it can bring a lot of benefits for you,” Dr, Suntchai said.

 

Talk more with Urologists team in M Centre, BNH Hospital